Letters Harm reduction in fight against HIV

Harm reduction interventions should encompass people who inject image and performance enhancing drugs

BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i1889 (Published 05 April 2016) Cite this as: BMJ 2016;353:i1889
  1. Jim McVeigh, director1,
  2. Andreas Kimergård, principal research fellow2,
  3. Geoff Bates, public health researcher1,
  4. Vivian D Hope, principal scientist3,
  5. Fortune Ncube, consultant epidemiologist3
  1. 1Centre for Public Health, Liverpool John Moores University, Liverpool L3 2ET, UK
  2. 2Addictions Department, King’s College London, London, UK
  3. 3National Infection Service, Public Health England, London, UK
  1. J.McVeigh{at}ljmu.ac.uk

We welcome the news item on the role of harm reduction in the “fight” against HIV,1 and we broadly agree with the findings of the report The Case for a Harm Reduction Decade: Progress, Potential and Paradigm Shifts.2 Clearly harm reduction for people who inject drugs is having a positive impact on HIV in many places around …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe